Related Experiment Video
Updated: May 30, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B
John H Contois1, G Russell Warnick, Allan D Sniderman
1Maine Standards Company, 765 Roosevelt Trail, Windham, ME 04062, USA. jcontois@mainestandards.com
Insights
Laboratory measurements for low-density lipoprotein cholesterol (LDL-C) and related markers are often unreliable due to method variability. Apolipoprotein B may offer a more consistent alternative for cardiovascular risk assessment.
Area of Science:
- Clinical Chemistry
- Cardiovascular Diagnostics
- Laboratory Medicine
Background:
- Clinicians have limited understanding of laboratory measurement reliability.
- Low-density lipoprotein cholesterol (LDL-C) is crucial for cardiovascular risk assessment but prone to errors.
- Existing LDL-C assays may not be standardized across different manufacturers.
Purpose of the Study:
- To review accuracy and precision issues in LDL-C measurement.
- To examine reliability of non-high-density lipoprotein cholesterol (non-HDL-C) and apolipoprotein B assays.
- To identify sources of variability in lipid measurements.
Main Methods:
- Literature review of studies on LDL-C, non-HDL-C, and apolipoprotein B measurement accuracy and precision.
- Analysis of data regarding inter-method variability and bias.
- Examination of the impact of LDL and HDL particle heterogeneity on assay results.
Main Results:
- LDL-C measurements show significant variability between different manufacturers' methods.
- Direct HDL-C assays exhibit similar problems, impacting non-HDL-C reliability.
- Method-specific biases stem from ambiguous definitions of LDL/HDL and particle heterogeneity.
Conclusions:
- Current LDL-C and non-HDL-C measurements may lack standardization and reproducibility.
- Apolipoprotein B shows potential as a more reliable marker but requires further validation.
- Addressing assay standardization and definition clarity is essential for accurate cardiovascular risk assessment.
Abstract:
There is little understanding of the reliability of laboratory measurements among clinicians. Low-density lipoprotein cholesterol (LDL-C) measurement is the cornerstone of cardiovascular risk assessment and prevention, but it is fraught with error. Therefore, we have reviewed issues related to accuracy and precision for the measurement of LDL-C and the related markers non-high-density lipoprotein cholesterol (non-HDL-C) and apolipoprotein B. Despite the widespread belief that LDL-C is standardized and reproducible, available data suggest that results can vary significantly as the result of methods from different manufacturers. Similar problems with direct HDL-C assays raise concerns about the reliability of non-HDL-C measurement. The root cause of method-specific bias relates to the ambiguity in the definition of both LDL and HDL, and the heterogeneity of LDL and HDL particle size and composition. Apolipoprotein B appears to provide a more reliable alternative, but assays for it have not been as rigorously tested as direct LDL-C and HDL-C assays.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Measurement of Bioavailability: Pharmacodynamic Methods
